[go: up one dir, main page]

MY207816A - Composition comprising lactic acid bacteria derived from green tea for caring damages of skin cells by microdust - Google Patents

Composition comprising lactic acid bacteria derived from green tea for caring damages of skin cells by microdust

Info

Publication number
MY207816A
MY207816A MYPI2020001900A MYPI2020001900A MY207816A MY 207816 A MY207816 A MY 207816A MY PI2020001900 A MYPI2020001900 A MY PI2020001900A MY PI2020001900 A MYPI2020001900 A MY PI2020001900A MY 207816 A MY207816 A MY 207816A
Authority
MY
Malaysia
Prior art keywords
composition
lactic acid
acid bacteria
green tea
skin cells
Prior art date
Application number
MYPI2020001900A
Other languages
English (en)
Inventor
Seung Hyun Shin
Kilsun Myoung
Yongjoo Na
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of MY207816A publication Critical patent/MY207816A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MYPI2020001900A 2017-10-31 2018-08-17 Composition comprising lactic acid bacteria derived from green tea for caring damages of skin cells by microdust MY207816A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170143715A KR101993270B1 (ko) 2017-10-31 2017-10-31 녹차 유래 유산균을 포함하는 미세먼지에 의한 피부 세포 손상 케어용 조성물
PCT/KR2018/009465 WO2019088421A1 (fr) 2017-10-31 2018-08-17 Composition pour le traitement de lésions de cellules cutanées provoquées par les poussières fines, contenant des bactéries lactiques dérivées du thé vert

Publications (1)

Publication Number Publication Date
MY207816A true MY207816A (en) 2025-03-20

Family

ID=66333319

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2020001900A MY207816A (en) 2017-10-31 2018-08-17 Composition comprising lactic acid bacteria derived from green tea for caring damages of skin cells by microdust

Country Status (5)

Country Link
KR (1) KR101993270B1 (fr)
CN (1) CN111315357B (fr)
MY (1) MY207816A (fr)
SG (1) SG11202003493VA (fr)
WO (1) WO2019088421A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102842911B1 (ko) 2020-02-17 2025-08-08 (주)아모레퍼시픽 미세먼지에 의한 가려움 완화용 조성물
KR102668566B1 (ko) * 2022-07-06 2024-06-10 주식회사 현대바이오랜드 수분 친화적 피부 마이크로바이옴에 대한 선택적 조절효능을 가진 락토바실러스 플란타럼 hdb 균주 및 이를 포함하는 화장료 조성물
KR102574601B1 (ko) * 2022-11-04 2023-09-08 엘앤피코스메틱(주) 티트리 추출물을 포함하는 화장료 조성물의 제조방법 및 이로부터 제조된 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2704704B1 (fr) * 2011-05-03 2018-09-26 DuPont Nutrition Biosciences ApS Bacteries probiotiques pour le traitement topique des maladies cutanées.
KR101998210B1 (ko) * 2012-10-31 2019-07-10 (주)아모레퍼시픽 녹차 유산균을 포함하는 피부 각질 제거용 조성물
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물

Also Published As

Publication number Publication date
KR101993270B1 (ko) 2019-06-26
KR20190048613A (ko) 2019-05-09
WO2019088421A1 (fr) 2019-05-09
SG11202003493VA (en) 2020-05-28
CN111315357B (zh) 2023-05-05
CN111315357A (zh) 2020-06-19

Similar Documents

Publication Publication Date Title
ZA202002094B (en) Trispecific proteins and methods of use
MX2021011119A (es) Nueva cepa de paenibacillus, compuestos antifungicos y metodos para su uso.
MY207816A (en) Composition comprising lactic acid bacteria derived from green tea for caring damages of skin cells by microdust
EP3718560A3 (fr) Inhibiteurs de kinases dépendant de la cycline et leurs procédés d'utilisation
WO2012157978A3 (fr) Extraits de daphne genkwa, et composition pharmaceutique contenant des fractions desdits extraits ou des composés séparés desdits extraits en tant que principes actifs, dans la prévention ou le traitement de la dermatite atopique
WO2012040804A3 (fr) Combinaisons synergiques de triazoles, strobilurines et de benzimidazoles, leurs utilisations, formulations, leurs procédés de production et leurs applications
NZ593802A (en) Plant extracts from acronychia species and their use
NZ708821A (en) Lfa-1 inhibitor formulations
EP2898923A3 (fr) Isoflavones pour la régulation de l'expression d'un gène sirtuine
WO2012064146A3 (fr) Composition anticancéreuse contenant gkn 1
MX2018010264A (es) Formulaciones libres de solventes de sustancias activas de bajo punto de fusion.
MX2020012499A (es) Compuestos heterocondensados de piridonas y su uso como inhibidores de la idh.
WO2019112161A3 (fr) Composition de milieu pour la prolifération cellulaire, la régénération de la peau et l'amélioration des rides comprenant, en tant que principe actif, un milieu conditionné de cellules souches pluripotentes, de cellules souches neurales ou de fibroblastes embryonnaires qui sont isolés à partir d'œufs aviaires
WO2016186349A3 (fr) Composition, contenant un extrait de quisaqualis indica, pour la prévention ou le traitement de l'hyperplasie prostatique
MY197442A (en) Novel compounds and their use in the treatment of schistosomiasis
HK1246206A1 (zh) 用於治疗青光眼的组合物和方法
WO2010120150A3 (fr) Composition de matière cosmétique
WO2019079698A8 (fr) Produits de tissu présentant des variations de propriétés mécaniques et procédés de traitement
IL289516A (en) A new peptide, compounds and method for the delivery of factors to cells and tissues
WO2012108748A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin
WO2021216687A9 (fr) Peptides pour traitement de la covid-19
MX2021003749A (es) Composicion farmaceutica para prevenir o tratar la enfermedad de fabry, que contiene inhibidor de la proteina trombospondina (tsp1) como ingrediente activo.
MY209771A (en) Compounds for use in the treatment of fascioliasis
WO2009145411A9 (fr) Compositions utilisées pour la prévention ou le traitement du cancer du côlon, contenant des extraits d'épines de gleditsia sinensis
WO2012108747A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de la racine d'helena